Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (3)
  • 2023 (4)
  • 2022 (13)
  • 2021 (4)
  • 2020 (6)
  • 2019 (4)
  • 2003 (0)

Subject

  • Drug Trafficking (2)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Prescription Drugs (2)
  • Arrests/Convictions - Major (1)
  • Dark Web- Internet Trafficking (1)
  • Diversion Division (1)
  • Major Law Enforcement Operation (1)
  • OCDETF/Task Force (1)
  • Seizures (Drugs/Property) (1)
  • Synthetic drugs (1)
  • Task Forces/Task Force Officers (1)

Drug Name

  • Fentanyl (267)
  • Methamphetamine (256)
  • Cocaine (246)
  • Heroin (151)
  • Oxycodone (58)
  • Marijuana (Cannabis) (52)
  • Opioids (52)
  • Synthetic Opioids (28)
  • Benzodiazepines (9)
  • Amphetamines (8)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • K2/Spice (3)
  • Methadone (3)
  • Ketamine (2)
  • Steroids (2)
  • LSD (1)
  • Marijuana Concentrates (1)
  • Hydromorphone (4)

Field Division

  • Washington, DC (2)
  • St. Louis (1)
Clear All Results
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

Noviembre 01, 2021
KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
Noviembre 01, 2021
PRESS RELEASE

Highlands County Drug Traffickers Sentenced to Federal Prison

Septiembre 09, 2021
MIAMI – Several Highlands County men have been sentenced in South Florida federal district court to prison terms for their roles in a powder and crack cocaine drug trafficking ring that had become entrenched in the Lake Placid neighborhood of Highway Park, Florida. A law enforcement operation handled by the...
Septiembre 09, 2021
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

Mayo 12, 2021
ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
Mayo 12, 2021
PRESS RELEASE

Former Roanoke pharmacist sentenced for tampering with powerful narcotics

Enero 29, 2021
ROANOKE, Va. – Bryan Wade Lewis, a former pharmacist at Home Choice Partners in Roanoke, was sentenced yesterday in U.S. District Court for tampering with a consumer product, hydromorphone, that affected interstate commerce. Jarod Forget, Special Agent in Charge of the DEA's Washington Division and Acting United States Attorney Daniel...
Enero 29, 2021
Showing 1 - 4 of 4 results

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español